Affordable Supplements | Caffeine Description by David Tolson

1. Introduction

Caffeine is the most widely consumed psychoactive substance in the western world. In addition to being a CNS stimulant, it has a variety of peripheral effects relating to muscle contraction, diuresis, gastric secretion, and lipolysis. The average US citizen consumes 206 mg of caffeine daily (the equivalent of about two cups of coffee), and 10% of the adult population ingests more than 1000 mg of caffeine daily¹. Despite this, there are many significant gaps in our understanding of the effects caffeine has on various systems². This article will explore the application caffeine has for the athlete, as well as a myriad of other effects of caffeine.

Chemically, caffeine (1,3,7-trimethylxanthine) is a member of a class of drugs known as methylxanthines. The primary pharmacological effect of caffeine is selective antagonism of the adenosine A1 and A2A receptors^3-4. Adenosine is a cellular constituent that modulates the release and activity of a variety of neurotransmitters, including norepinephrine, acetylcholine, dopamine, and GABA. It primarily inhibits the release of excitatory neurotransmitters, so increased concentrations of adenosine reduce arousal and suppress spontaneous behavioral activity³. Adenosine concentrations slowly increase during wakefulness, so adenosine antagonism is what causes caffeine's wake-promoting effect. Other effects of caffeine include inhibition of phosphodiesterase (PDE), GABA-A blockade, and mobilization of intracellular calcium. The relevance of these effects at normal doses is debatable.

After ingestion, caffeine is absorbed into the blood and other body tissues within 5 minutes, and peak concentration is reached in about half an hour, and the half-life is approximately 4 hours⁵. The ideal dosage for achieving various goals will be discussed further in the following sections.

2. Caffeine and exercise performance

The beneficial effect caffeine has on endurance exercise is well established, and has been confirmed in a multitude of studies³. During submaximal exercise, caffeine in doses of 3-9 mg/kg (200-900 mg) delays fatigue considerably, increasing exercise time by 20-50%^{3, 6}, with the 3-6 mg/kg range appearing to be ideal⁴. Lower doses, such as 1.5 mg/kg, appear to offer at least some benefit⁶. The magnitude of the beneficial effect depends on a variety of factors, such as type and intensity of exercise (the greatest effect is seen in exercise lasting 30-120 minutes), previous caffeine use (with greater and longer lasting effects among nonusers), training status, and individual variation^{3-4, 7}. Although many of these studies are conducted in the fasted state, which does not reflect realistic conditions, the benefit is still seen in studies in which the subjects are well fed⁶. Using caffeine to improve endurance performance is also quite safe. Doses as high as 10 mg/kg do not impair thermoregulation during exercise⁸, and exercise prevents the effects caffeine has on diuresis, so hydration status is not compromised ⁹.

Whether or not caffeine has a benefit for those engaged in short-term, high-intensity exercise (over 100% VO2max) such as strength training or sprinting is less clear, although the bulk of the evidence suggests a more modest benefit of a 10-25% increase in work output^10-11. However, this effect still appears to be more pronounced in exercise bouts lasting over 60 seconds¹⁰. Few well-controlled studies have been done assessing whether or not caffeine has a benefit for strength trainers, but those that have been done have had positive results¹¹.

There are a few supplements which caffeine may interact with either positively or negatively. Caffeine and carnitine synergistically improve endurance exercise time¹². The issue of whether or not caffeine and creatine should be combined is controversial. Two studies indicate that they may be antagonistic. One study found that caffeine and creatine have opposing effects on muscle relaxation time¹¹, but the importance of this is not clear. Another widely quoted study found that when caffeine and creatine were co-administered over a period of six days, caffeine prevented the beneficial effect of creatine¹⁰. On the other hand, when caffeine is administered acutely before exercise during creatine loading the effect caffeine has on athletic performance still remains¹⁰. This indicates that chronic caffeine consumption may interfere with the benefit of creatine, but that creatine does not interfere with the improvement of exercise performance from caffeine. Unfortunately, there is not yet enough research to draw any practical conclusions. It is doubtful that caffeine completely prevents the action of creatine, as creatine functions through multiple pathways, but whether or not there will be on balance a greater effect from creatine by itself or from creatine along with caffeine pre-exercise is unknown.

3. Mechanism of action

A number of mechanisms of action for the ergogenic effect of caffeine have been proposed in the literature; some hold up to scrutiny while others do not. The original theory, known as the metabolic theory, was that the effect was primarily due to mobilization of free fatty acids, which would preferentially promote fat as a fuel source during exercise and spare muscle glycogen. In recent years, a multitude of studies have indicated that this is an unlikely reason for the benefit, and this theory has been rejected^{3, 6}. A number of more promising theories have arisen, primarily involving effects on both the central and peripheral nervous system.

A major role of the central nervous system (CNS) is supported in many ways. Intracerebroventricular administration of caffeine to rats, which results in high CNS levels and negligible peripheral levels, increases run time by 60%³. A primary role of adenosine antagonism is implicated in this area, since adenosine inhibits the release of dopamine and increases the serotonin/dopamine ratio, and both of these may play a role in central fatigue during exercise ³. In line with this theory, administration of a selective adenosine agonist reduced run time to fatigue in rats and caffeine reversed this effect³.

There are also a variety of ways in which caffeine may improve neuromuscular function. These include changes in the chemical composition of the muscle's environment, alteration of feedforward inhibition, or alteration in central processing of feedforward or feedback¹⁴. This is where potentiation of calcium release plays a possible role^15-16. In vitro, potentiation of the release of calcium from the sarcoplasmic reticulum occurs at levels that are obtainable in ergogenic doses in humans¹⁵. In line with this, doses of caffeine from 4 to 7 mg/kg potentiate submaximal skeletal muscle contraction, with no effect of tolerance¹⁵. This mechanism of action would also explain why caffeine appears to be more effective at lower exercise intensities, as the level of calcium release from the sarcoplasmic reticulum is thought to play an important role in fatigue at these intensities, but not higher intensities¹⁵. Caffeine may also improve neuromuscular function via adenosine antagonism. Specifically, it may reduce the inhibitory action adenosine has on motor neuron firing frequency and raise the frequency of potentials in the motor end plate through acetylcholine release¹⁶. Finally, it has been suggested that caffeine reduces fatigue by preventing loss of potassium from skeletal muscle¹⁰. This would be achieved by increased Na2+/K+ ATPase activity, leading to increased potassium ion uptake¹⁰. However, there is little evidence to support this theory at this point.

A final mechanism of action for improvement of exercise performance by caffeine is analgesia. One of the effects of caffeine on exercise is a lower rating of perceived exertion (RPE). Caffeine increases the pain threshold and tolerance to pain¹⁷. It has also specifically been shown to have an analgesic effect during ischemic muscle contractions¹⁰. This is related to caffeine's ability to increase the release of beta-endorphins and other hormones and neurotransmitters that influence perception of pain¹⁰.

4. Caffeine and weight loss

Almost every weight loss pill in the market contains caffeine, and there is good reason for it. Caffeine has well known thermogenic properties in humans, increasing the rate of lipolysis and total energy expenditure, and it also decreases food intake^18-20. However, caffeine by itself rarely results in statistically significant weight loss unless it is used in high doses (a gram or more daily). Luckily, there are a variety of substances that caffeine exhibits potent synergistic relationships with. In addition to oral administration, clinical studies indicate that caffeine is an effective topical fat loss agent, especially in "stubborn" areas, when the right carrier is used²¹. This may be a particularly effective route of administration, since caffeine induces insulin resistance in adipocytes².

The mechanisms of action for fat loss are relatively well established. Adenosine is one of the negative feedback mechanisms that prevents the release of the lipolytic hormone norepinephrine (NE)⁵. Caffeine also inhibits PDE, which results in higher concentrations of cyclic AMP, and this potentiates the effect of NE¹⁹. The inhibition of these two negative feedback mechanisms makes caffeine particularly useful when used in conjunction with an agent that causes release of NE or other catecholamines.

Caffeine also may exhibit a synergistic relationship with EGCG, a component of green tea. This is because EGCG inhibits COMT, an enzyme that breaks down NE and other catecholamines²². The combination of caffeine, carnitine, and choline causes fat loss in rats²³. Caffeine together with capsaicin increases thermogenesis in humans, but it is not known if this was due to additive or synergistic effects²⁰. Finally, caffeine and nicotine make an effective combination for fat loss¹⁸. One study found that 100 mg of caffeine along with 1 mg of nicotine gum significantly increased thermogenesis and increased resting metabolic rate by 8.5%. Raising the nicotine dose to 2 mg had little added benefit but significantly increased side effects. Also, despite the fact that caffeine raises blood pressure, it protects against the blood pressure raise from nicotine¹. However, the two substances may potentiate the addictive effect of one another²⁴. If a synergistic substance is being used, the ideal dose of caffeine for fat loss seems to be in the range of 200-400 mg daily, with little added benefit from higher doses.

5. Fatigue, cognitive performance, and sleep

Caffeine, usually in doses in the 150-400 mg range, acutely improves cognitive function in a multitude of ways. These primarily involve simple intellectual tasks and rapid information processing⁵. Beneficial effects seen from caffeine include faster typing with fewer errors, improved simple reaction and choice reaction time, improved performance on simulations of driving and sentry duty, improved performance on digit symbol substitution and logical reasoning tasks, improved accuracy of time estimation, and improved cognitive performance in the post-exercise state^{5, 25-28}. Chronic or lifetime consumption of caffeine is associated with improved cognitive function in some studies, primarily on the elderly^{25, 32}. However, the effects caffeine has on more complex tasks are not clear, and caffeine has a negative impact on fine motor coordination^{5, 25}.

Caffeine also effectively combats fatigue and the negative effects of sleep deprivation. Improved cognitive function from caffeine has been demonstrated for up to 64 hours of sleep deprivation, and one study indicates that it is as effective as the prescription drug modafinil in increasing alertness during sleep deprivation^29-30. Improved marksmanship and driving ability during sleep deprivation have also been demonstrated^{5, 31}. Caffeine also reduces cognitive impairment due to benzodiazapenes, alcohol, and illness ²⁵. Numerous effects on sleep itself are also associated with caffeine. Acute administration increases sleep latency and decreases sleep duration. One study found that there was an inverse relationship between chronic caffeine intake and sleep duration, but no relationship with sleep satisfaction²⁵. However, three other studies have found no relationship between chronic intake and sleep variables²⁵.

An important consideration when discussing cognitive enhancement from caffeine is the effects of withdrawal. Headache is the most common symptom of caffeine withdrawal, but other effects noted include irritability, sleepiness, dysphoria, delerium, nausea, nervousness, restlessness, anxiety, and muscle tension ^{5, 34}. According to some sources, caffeine does not improve cognition in and of itself, but the improvement seen in studies is due to reversal of caffeine withdrawal. This is known as the "withdrawal reversal hypothesis." In support for this hypothesis, studies find greater cognitive improvement from caffeine in regular users undergoing withdrawal than in nonusers³³. This would indicate that the withdrawal reversal hypothesis is at least partially true. However, there are a number of flaws in this hypothesis. First, it does not account for the behavioral changes seen in animal studies or in non-consumers. Second, the studies cannot be considered to be blinded, since users are specifically told to abstain from caffeine. Also, despite the fact that caffeine withdrawal increases anxiety and depression, few studies indicate that it significantly decreases cognitive performance, and when it does the effects are mild²⁵. Finally, certain individuals may not use caffeine because it is ineffective in their case (individual response varies considerably), so the nonusers used in withdrawal reversal studies may be predisposed to derive little benefit from caffeine to begin with³³.

6. Other effects & precautions

Hydration status - A common concern is that caffeine will compromise fluid balance. However, the effect caffeine has is minor, and it goes away with tolerance. A review of 10 studies found only small differences in fluid retention with caffeinated beverages (containing 100-680 mg) compared to an equal amount of water⁴⁷.
Cardiovascular - Caffeine (and especially coffee) should be avoided by those with high blood pressure or at high risk for cardiovascular disease. Since adenosine is a vasodilator, adenosine antagonism raises blood pressure⁵. Tolerance develops to this effect, but it is incomplete²⁶. Caffeine also raises homocysteine levels, but not as much as coffee⁴⁸. In line with these effects, caffeine intake has been associated with increased risk of heart attack¹.
Insulin resistance - Acute administration of caffeine (the equivalent of 3-4 cups of coffee, in other words 300-400 mg) causes insulin resistance in sedentary males with skeletal muscle as a major contributing factor, although this only occurs in the presence of above normal insulin levels². Also, tolerance to this effect develops¹⁸. Possible mechanisms of action include adenosine antagonism in skeletal muscle, increase in FFAs, and increased epinephrine concentration (the most likely cause, since caffeine-induced insulin resistance is reversed by the beta blocker propranolol)^{2, 49}. Caffeine does not impair exercise-induced increases in insulin sensitivity, indicating that the effects are independent of one another². Although caffeine significantly improves athletic performance, if one is trying to gain appreciable amounts of muscle mass, using large doses of caffeine pre-workout may not be a good idea as inhibition of muscle glucose uptake may be counterproductive to that goal.
Anxiety/stress - Large doses of caffeine (over 300 mg) promote anxiety, but this effect does not cross over to small doses except in select individuals (such as caffeine naive individuals, in which even 150 mg can be anxiogenic, or those with anxiety sensitivity)^{17, 25, 50}. Lower doses are usually neutral or decrease anxiety²⁵. Also, exercise is antagonistic towards caffeine-induced anxiogenesis⁵¹. Chronic daily intake of over 1000 mg daily is associated with chronic anxiety or "caffeinism," but causality has not been determined – it could be that anxiety leads to high caffeine intake, and not vice versa²⁵. Those who easily become anxious should avoid caffeine.
Tolerance & addiction - It is clear that tolerance does not develop to all of the effects of caffeine. According to one study, tolerance develops to the peripheral effects but not the central ones, while another study found that tolerance to both central and peripheral effects was incomplete ²⁶. There is at least some degree of CNS tolerance, as regular caffeine administration causes upregulation of adenosine receptors in the brain⁴. It takes about 20 hours for caffeine tolerance to wear off²⁶. Caffeine is also addictive, but chronic caffeine use is generally regarded as safe except in select populations. Of more concern is that caffeine can potentiate the addictive effect of other drugs by increasing dopamine receptor sensitivity ⁵².
Bone density - Caffeine is associated with lower bone mineral density, especially in elderly women. However, there is no association if calcium intake is over 75% of the RDA⁵⁷.
Drug combinations - A number of drugs that inhibit the enzymes that metabolize caffeine may have negative interactions with caffeine. These include fluvoxamine, mexiletine, clozapine, psoralens, idrocilamide, phenylpropanolamine, furafylline, theophylline, and enoxacin^53-54. Caffeine should also be used with caution when combined with large doses of other stimulants. Additionally, caffeine can exacerbate kidney and liver toxicity from some substances such as acetaminophen and alcohol^55-56, but this primarily becomes an issue when these substances are used in excess.

If you have any questions or comments regarding this article, please email dvdtlsn@bulknutrition.com.

No part of this article may be reproduced in any form without the permission of David Tolson or Mike McCandless.

References

1. Cogn Brain Res. 2002 May;13(3):407-15. Maximum cognitive performance and physiological time trend measurements after caffeine intake. Kourtidou-Papadeli C, Papadelis C, Louizos AL, Guiba-Tziampiri O.

2. Diabetes. 2002 Mar;51(3):583-90. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Thong FS, Derave W, Kiens B, Graham TE, Urso B, Wojtaszewski JF, Hansen BF, Richter EA.

3. Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R399-404. Epub 2002 Oct 24. Central nervous system effects of caffeine and adenosine on fatigue. Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA.

4. J Appl Physiol. 2002 Oct;93(4):1227-34. Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. Bell DG, McLellan TM.

5. Brain Cogn. 2003 Feb;51(1):143-54. Effects of mental workload and caffeine on catecholamines and blood pressure compared to performance variations. Papadelis C, Kourtidou-Papadeli C, Vlachogiannis E, Skepastianos P, Bamidis P, Maglaveras N, Pappas K.

6. J Appl Physiol. 2002 Sep;93(3):990-9. Effect of different protocols of caffeine intake on metabolism and endurance performance. Cox GR, Desbrow B, Montgomery PG, Anderson ME, Bruce CR, Macrides TA, Martin DT, Moquin A, Roberts A, Hawley JA, Burke LM.

7. Neurosci Lett. 2001 Jul 27;308(1):25-8. Caffeine inhibits exercise-induced increase in tryptophan hydroxylase expression in dorsal and median raphe of Sprague-Dawley rats. Lim BV, Jang MH, Shin MC, Kim HB, Kim YJ, Kim YP, Chung JH, Kim H, Shin MS, Kim SS, Kim EH, Kim CJ.

8. Aviat Space Environ Med. 1998 Dec;69(12):1178-81. Thermoregulatory effects of caffeine ingestion during submaximal exercise in men. Dunagan N, Greenleaf JE, Cisar CJ.

9. J Appl Physiol. 1998 Aug;85(2):709-15. Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance. Kovacs EM, Stegen JHCH, Brouns F.

10. Med Sci Sports Exerc. 2002 Nov;34(11):1785-92. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Doherty M, Smith PM, Davison RC, Hughes MG.Pediatrics. 2003 Jan;111(1):42-6. Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pollak CP, Bright D.

11. J Appl Physiol. 2002 Feb;92(2):513-8. Opposite actions of caffeine and creatine on muscle relaxation time in humans. Hespel P, Op't Eijnde B, Van Leemputte M.

12. J Nutr Sci Vitaminol (Tokyo). 2001 Dec;47(6):378-84. Effects of carnitine coingested caffeine on carnitine metabolism and endurance capacity in athletes. Cha YS, Choi SK, Suh H, Lee SN, Cho D, Li K.

13. JAMA 2003 Mar 26;289(12):1537-45. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J.

14. J Appl Physiol. 2001 Oct;91(4):1535-44. Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions. Plaskett CJ, Cafarelli E.

15. J Appl Physiol. 2000 Nov;89(5):1719-24. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. Tarnopolsky M, Cupido C.

16. Jpn J Physiol. 2001 Dec;51(6):761-4. Caffeine ingestion attenuates the VO(2) slow component during intense exercise. Santalla A, Lucia A, Perez M.

17. Psychopharmacology (Berl). 2002 Dec;164(4):429-31. Epub 2002 Oct 24. The moderating effect of anxiety sensitivity on caffeine-induced hypoalgesia in healthy women. Keogh E, Chaloner N.

18. Am J Clin Nutr. 2003 Jun;77(6):1442-7. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Jessen AB, Toubro S, Astrup A.

19. Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):391-4. Effects of caffeine on the uncoupling protein family in obese yellow KK mice. Kogure A, Sakane N, Takakura Y, Umekawa T, Yoshioka K, Nishino H, Yamamoto T, Kawada T, Yoshikawa T, Yoshida T.

20. Br J Nutr. 2001 Feb;85(2):203-11. Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Yoshioka M, Doucet E, Drapeau V, Dionne I, Tremblay A.

21. Dermatol Surg. 1999 Jun;25(6):455-62. Modification of subcutaneous adipose tissue by a methylxanthine formulation: a double-blind controlled study. Lesser T, Ritvo E, Moy LS.

22. Phytomedicine. 2002 Jan;9(1):3-8. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Chantre P, Lairon D.

23. J Nutr. 2000 Feb;130(2):152-7. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. Hongu N, Sachan DS.

24. Psychopharmacology (Berl). 2003 Jan;165(3):280-90. Epub 2002 Nov 14. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Jones HE, Griffiths RR.

25. Food Chem Toxicol. 2002 Sep;40(9):1243-55. Effects of caffeine on human behavior. Smith A.

26. Br J Clin Pharmacol. 2002 Oct;54(4):400-6. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Watson J, Deary I, Kerr D.

27. Hum Psychopharmacol. 2002 Oct;17(7):361-7. Evidence for a relationship between daily caffeine consumption and accuracy of time estimation. Stine MM, O'Connor RJ, Yatko BR, Grunberg NE, Klein LC.

28. Int J Sports Med. 1999 Aug;20(6):354-61. Caffeine improves cognitive performance after strenuous physical exercise. Hogervorst E, Riedel WJ, Kovacs E, Brouns F, Jolles J.

29. J Sleep Res. 2001 Dec;10(4):265-76. Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. Beaumont M, Batejat D, Pierard C, Coste O, Doireau P, Van Beers P, Chauffard F, Chassard D, Enslen M, Denis JB, Lagarde D.

30. Psychopharmacology (Berl). 2002 Jan;159(3):238-47. Epub 2001 Oct 19. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ.

31. Aviat Space Environ Med. 2003 Apr;74(4):309-14. Caffeine effects on marksmanship during high-stress military training with 72 hour sleep deprivation. Tharion WJ, Shukitt-Hale B, Lieberman HR.

32. Am J Epidemiol. 2002 Nov 1;156(9):842-50. Coffee consumption and cognitive function among older adults. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D.

33. Psychopharmacology (Berl). 2003 Apr;167(1):54-62. Epub 2003 Feb 25. Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ.

34. Food Chem Toxicol. 2002 Sep;40(9):1257-61. Caffeine: behavioral effects of withdrawal and related issues. Dews PB, O'Brien CP, Bergman J.

35. Cochrane Database Syst Rev. 2001;(4):CD001112. Caffeine for asthma. Bara AI, Barley EA.

36. Curr Pain Headache Rep. 2001 Oct;5(5):472-8. The use of ibuprofen plus caffeine to treat tension-type headache. Diamond S, Freitag FG.

37. Eur J Appl Physiol. 2001 Jul;85(1-2):144-50. Resynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatonin. Pierard C, Beaumont M, Enslen M, Chauffard F, Tan DX, Reiter RJ, Fontan A, French J, Coste O, Lagarde D.

38. Clin Chim Acta. 2000 May;295(1-2):141-54. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Lee C.

39. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12455-60. Epub 2002 Aug 30. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS, Huang MT, Conney AH.

40. Cancer Res. 2001 Jul 1;61(13):5002-9. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, Conney AH.

41. Indian J Exp Biol. 2001 Dec;39(12):1254-7. Radioprotective action of caffeine: use of Saccharomyces cerevisiae as a test system. Vaidya PJ, Pasupathy K.

42. Cancer Lett. 2003 May 8;194(1):25-35. Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Takeshita F, Ogawa K, Asamoto M, Shirai T.

43. J Exp Clin Cancer Res. 2001 Jun;20(2):287-92. Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. Gude RP, Menon LG, Rao SG.

44. Stroke. 2003 May;34(5):1242-5. Epub 2003 Apr 10. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC.

45. Eur J Neurol. 2002 Jul;9(4):377-82. Does caffeine intake protect from Alzheimer's disease? Maia L, de Mendonca A.

46. Ann Neurol. 2001 Jul;50(1):56-63. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC.

47. Int J Sport Nutr Exerc Metab. 2002 Jun;12(2):189-206. Caffeine, body fluid-electrolyte balance, and exercise performance. Armstrong LE.

48. Am J Clin Nutr. 2002 Dec;76(6):1244-8. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB.

49. J Appl Physiol. 2002 Jun;92(6):2347-52. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. Thong FS, Graham TE.

50. Neuropsychopharmacology. 2003 Sep;28(9):1694-702. Epub 2003 Jun 25. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Alsene K, Deckert J, Sand P, de Wit H.

51. Hum Psychopharmacol. 2002 Apr;17(3):151-6. Interactions between alcohol and caffeine in relation to psychomotor speed and accuracy. Mackay M, Tiplady B, Scholey AB.

52. Psychopharmacology (Berl). 2002 Jul;162(3):246-54. Epub 2002 May 14. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Cauli O, Morelli M.

53. Clin Pharmacol Ther. 2002 Mar;71(3):141-52. Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Christensen M, Tybring G, Mihara K, Yasui-Furokori N, Carrillo JA, Ramos SI, Andersson K, Dahl ML, Bertilsson L.

54. Clin Pharmacokinet. 2000 Aug;39(2):127-53. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Carrillo JA, Benitez J.

55. J Pharmacol Exp Ther. 2003 Jul;306(1):35-42. Epub 2003 Mar 27. Toxicity of acetaminophen, salicylic acid, and caffeine for first-passage rat renal inner medullary collecting duct cells. Cai Q, Dmitrieva NI, Michea LF, Rocha G, Ferguson D, Burg MB.

56. Toxicol Appl Pharmacol. 2002 Dec 1;185(2):91-7. Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol. DiPetrillo K, Wood S, Kostrubsky V, Chatfield K, Bement J, Wrighton S, Jeffery E, Sinclair P, Sinclair J.

57. J Am Coll Nutr. 2002 Dec;21(6):536-44. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? Ilich JZ, Brownbill RA, Tamborini L, Crncevic-Orlic Z.